Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Neurology|October 9, 2002
Statins as immunomodulators: comparison with interferon-beta 1b in MSO Neuhaus, S Strasser-Fuchs, F Fazekas, et al.
Histopathology|May 18, 2018
Eosinophilic oesophagitis: relevance of mast cell infiltrationDaniel S Strasser, Shanon Seger, Christian Bussmann, et al.
British Journal of Clinical Pharmacology|October 13, 2016
Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949Anna K Stalder, Dominik Lott, Daniel S Strasser, et al.
Journal of Medicinal Chemistry|October 28, 2005
Comparative epitope mapping with saturation transfer difference NMR of sialyl Lewis(a) compounds and derivatives bound to a monoclonal antibodyLars Herfurth, Beat Ernst, Beatrice Wagner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 23, 2000
Apolipoprotein E genotype related differences in brain lesions of multiple sclerosisF Fazekas, S Strasser-Fuchs, H Schmidt, et al.
Magnetic Resonance in Medicine|October 12, 2000
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosisR Bammer, M Augustin, S Strasser-Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Brain activation patterns elicited by the 'Faces Symbol Test' -- a pilot fMRI studyRh Grabner, F Popotnig, S Ropele, et al.
Neurochemical Research|May 31, 2024
ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating EffectsLaetitia Pouzol, Anna Sassi, Mélanie Tunis, et al.
Clinical Pharmacology and Therapeutics|January 6, 2021
A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement BiomarkerChristine Huynh, Andrea Henrich, Daniel S Strasser, et al.
Pageof 10